Ovid Therapeutics Inc.
OVID · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $26 | $27 | $45 | $188 |
| Short-Term Investments | $27 | $79 | $84 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $4 | $2 | $3 |
| Total Curr. Assets | $56 | $110 | $131 | $190 |
| Property Plant & Equip (Net) | $13 | $15 | $16 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $21 | $18 | $6 | $4 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | $0 |
| Total NC Assets | $36 | $34 | $24 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $92 | $144 | $155 | $195 |
| Liabilities | – | – | – | – |
| Payables | $3 | $4 | $2 | $7 |
| Short-Term Debt | $1 | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $6 | $7 | $5 | $8 |
| Total Curr. Liab. | $11 | $11 | $7 | $15 |
| LT Debt | $13 | $15 | $16 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $30 | $0 | $0 |
| Total NC Liab. | $13 | $45 | $16 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $15 | $16 | $17 | $0 |
| Total Liabilities | $24 | $56 | $23 | $15 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$304 | -$278 | -$226 | -$171 |
| AOCI | -$0 | $0 | -$0 | $0 |
| Other Equity | $372 | $366 | $358 | $351 |
| Total Equity | $68 | $88 | $132 | $180 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $92 | $144 | $155 | $195 |
| Net Debt | -$12 | -$11 | -$28 | -$188 |